PharmVar GeneFocus: CYP2C19

Clin Pharmacol Ther. 2021 Feb;109(2):352-366. doi: 10.1002/cpt.1973. Epub 2020 Jul 22.

Abstract

The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. This GeneFocus provides a comprehensive overview and summary of CYP2C19 and describes how haplotype information catalogued by PharmVar is utilized by the Pharmacogenomics Knowledgebase and the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Alleles
  • Cytochrome P-450 CYP2C19 / genetics*
  • Genetic Variation / genetics
  • Genotype
  • Haplotypes / genetics
  • Humans
  • Knowledge Bases
  • Pharmacogenetics / methods

Substances

  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19